Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
0%
OVERLAP
BY WEIGHT
0
# OF OVERLAPPING
HOLDINGS
XBI
116
HOLDINGS
0%
ALSO IN BTEC
BTEC
267
HOLDINGS
nan%
ALSO IN XBI
SECTOR DRIFT (XBI minus BTEC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in BTEC |
Overlap | |
|---|---|---|---|---|
XBI Overweight Relative to BTEC
 |
ALNYLAM PHARMACEUTICALS INC | 3.3% |
|
INSMED INC | 3.2% |
|
UNITED THERAPEUTICS CORP | 3.2% |
|
HALOZYME THERAPEUTICS INC | 3.0% |
|
INCYTE CORP | 2.8% |
|
NEUROCRINE BIOSCIENCES INC | 2.5% |
|
ABBVIE INC | 2.4% |
|
REGENERON PHARMACEUTICALS | 2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.4% |
|
BRIDGEBIO PHARMA, INC. | 2.4% |
XBI Underweight Relative to BTEC
|
HUMACYTE, INC. | 0.1% |
|
CULLINAN ONCOLOGY, INC. | 0.1% |
|
ARRIVENT BIOPHARMA, INC. | 0.1% |
|
CAPRICOR THERAPEUTICS, INC. | 0.1% |
 |
ARBUTUS BIOPHARMA CORPORATION | 0.1% |
|
ALTIMMUNE, INC. | 0.1% |
|
TAYSHA GENE THERAPIES, INC. | 0.1% |
|
MIMEDX GROUP INC | 0.1% |
|
ORIC PHARMACEUTICALS INC | 0.1% |
|
REPLIMUNE GROUP, INC. | 0.1% |